CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients
Eun-Yeong Cho, Jung-Eun Cho, Eun-Bin Lee, Seung Soo Yoo, Jung Hyun Chang
Tuberc Respir Dis. 2023;86(1):33-46.   Published online November 28, 2022
DOI: https://doi.org/10.4046/trd.2022.0055

Excel Download

An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients
Tuberculosis and Respiratory Diseases. 2023;86(1):33-46   Crossref logo
Link1 Link2 Link3

Effects of Moderate Hepatic Impairment on the Pharmacokinetic Properties and Tolerability of Umeclidinium and Vilanterol in Inhalational Umeclidinium Monotherapy and Umeclidinium/Vilanterol Combination Therapy: An Open-Label, Nonrandomized Study
Clinical Therapeutics. 2014;36(7):1016-1027.e2   Crossref logo
Link1 Link2

Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study
International Journal of Chronic Obstructive Pulmonary Disease. 2013;159   Crossref logo
Link1

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
The Lancet Respiratory Medicine. 2014;2(6):472-486   Crossref logo
Link1 Link2

Safety and Effectiveness of Darunavir in Korean Patients with Human Immunodeficiency Virus 1 Infection: A Post-Marketing Observational Study
Infection & Chemotherapy. 2021;53(3):539   Crossref logo
Link1 Link2 Link3

Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study
Journal of Asthma and Allergy. 2021;Volume 14:809-819   Crossref logo
Link1 Link2

Long-Term Safety and Effectiveness of the Xanthine Oxidoreductase Inhibitor, Topiroxostat in Japanese Hyperuricemic Patients with or Without Gout: A 54-week Open-label, Multicenter, Post-marketing Observational Study
Clinical Drug Investigation. 2020;40(9):847-859   Crossref logo
Link1 Link2 Link3

WIN OVER study: Efficacy and safety of olmesartan in Indian hypertensive patients: Results of an open label, non-comparative, multi-centric, post marketing observational study
Indian Heart Journal. 2014;66(3):340-344   Crossref logo
Link1 Link2

An Open Label, Multi-Center, Non-Interventional Post-Marketing Surveillance to Monitor the Safety and Efficacy of ALTARGO® (Retapamulin) Administered in Korean Patients According to the Prescribing Information
Annals of Dermatology. 2018;30(4):441   Crossref logo
Link1 Link2 Link3

Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study
Advances in Therapy. 2020;37(5):2442-2459   Crossref logo
Link1 Link2 Link3